006 Luetic.p65
ثبت نشده
چکیده
( )* +,+ . / -,0,1)*,2 1 * 3 4 5 26 7 (,) ( 5& / 8 ) ,6 ,26 1)* 8 ) 6 9 3 / 8 / (,) , ) 6 9 / ( ,8 )+ * % ,70 6,8 4 / . ( ) 6 ( , ) 8 8 +,4 . 8 +6 3,2 * ( 8)*,2 9 3, :6& 3 )*,/ ( / +,+ . / ( / -,8 3 0 )3,/ ) ( )* ( 7 , ,(,7 * 63 )*,2 (6 5 3 / + * ( / -,8 , +,) *, 0 365 * ) ( / ; 36 / ( ) 6 9 / 0 ) 6 * 6 % 6 ( )8, ) ,26 4 )*-/ 4 3, ) 6 9 3 / ),. / )* ) ( -,0& ,1)*,2 1 * + / )*, 3 0 0 / ,3 ),. / +,-,9 /< ) + ( / % ( *, )8, ) ,/ 36( / ) *,/ 4 8,( 6 0 . /)* +6,. )
منابع مشابه
XI-006 induces potent p53-independent apoptosis in Ewing sarcoma
There is an imperious need for the development of novel therapeutics for the treatment of Ewing sarcoma, the second most prevalent solid bone tumour observed in children and young adolescents. Recently, a 4-nitrobenzofuroxan derivative, XI-006 (NSC207895) was shown to diminish MDM4 promoter activity in breast cancer cell lines. As amplification of MDM4 is frequently observed in sarcomas, this s...
متن کامل